Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
15 Août 2023 - 9:57PM
Edgar (US Regulatory)
|
SEC
FILE NUMBER |
|
001-40738 |
|
CUSIP
NUMBER |
|
75989R
107 |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
(Check
one): |
|
☐
Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q
☐
Form 10-D ☐ Form N-CEN ☐ Form N-CSR |
|
|
|
|
|
|
|
For
Period Ended: June 30, 2023 |
|
|
|
|
|
|
|
☐
Transition Report on Form 10-K |
|
|
|
|
|
|
|
☐
Transition Report on Form 20-F |
|
|
|
|
|
|
|
☐
Transition Report on Form 11-K |
|
|
|
|
|
|
|
☐
Transition Report on Form 10-Q |
|
|
|
|
|
|
|
For
the Transition Period Ended: |
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein. |
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
RENOVORX,
INC.
Full
Name of Registrant
Not
applicable
Former
Name if Applicable
4546
El Camino Real, Suite B1
Address
of Principal Executive Office (Street and Number)
Los
Altos, CA 94022
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
|
(a) |
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
☒ |
(b) |
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the
fifth calendar day following the prescribed due date; and |
|
(c) |
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III — NARRATIVE
RenovoRx,
Inc. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its
Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Q2 2023 Form 10-Q”) by the prescribed
due date because additional time is required to finalize the Company’s financial statements and related disclosures required to
be included in the Q2 2023 Form 10-Q.
The
Company is working diligently to complete the Q2 2023 Form 10-Q as soon as possible, and the Company expects to file such report within
the five-day extension period provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.
PART
IV — OTHER INFORMATION
(1) |
Name
and telephone number of person to contact in regard to this notification |
|
|
|
|
|
|
|
Shaun
R. Bagai |
|
650 |
|
284-4433 |
|
(Name)
|
|
(Area
Code) |
|
(Telephone
Number) |
|
|
|
|
|
|
(2) |
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If answer is no, identify report(s). Yes ☒ No ☐ |
|
|
|
|
|
|
|
|
|
|
|
|
(3) |
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof? Yes ☐ No ☒ |
|
|
|
|
|
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made. |
|
|
|
|
|
|
RenovoRx,
Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date
|
August 15, 2023 |
|
By |
/s/
Shaun R. Bagai |
|
|
|
Name: |
Shaun
R. Bagai |
|
|
|
Title:
|
Chief
Executive Officer |
RenovoRx (NASDAQ:RNXT)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
RenovoRx (NASDAQ:RNXT)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024